08.30 – 10.30
Electrocardiographic characteristics of patients with Ebstein’s anomaly before and after ablation of accessory pathways
S. Nava-Townsend/ Mexico City, Mexico
ECG and holter monitoring in Andersen-Tawil Syndrome
M.F. Márquez/ Mexico City, Mexico
10.45 – 12.30
Risk factors management to reduce the burden of AF
P. Sanders/ Adelaide, Australia
Procedural endpoints and predictors of long-term outcome after persistent AF ablation
Y.H. Kim/ Seoul, Korea
12.30 – 14.00
Automatic CRT optimization and follow up:
Clinical case 1 – monitoring
F. Zanon/ Rovigo, Italy
Automatic CRT optimization and follow up:
Clinical case 2 – optimization
G. Mascioli/ Bergamo, Italy
Multi area pacing to enlarge CRT effect
Clinical case 1
G. Zingarini/ Perugia, Italy
14.00 – 15.45
Cryoablation with new generation balloons
E. Hoffmann/ Munich, Germany
AF ablation targeting rotors
P. Wang/ San Diego, USA
16.15 – 18.00
Treatment of atrial fibrillation by advanced ablation technology
E.G. Vester / Düsseldorf, Germany